Cytek Biosciences, Inc. Common Stock CTKB
HEALTHCARE · MEDICAL DEVICESi
Market dataready · fetched 2026-11-11T13:51:09.944Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-10T21:41:31.171363581Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-11T13:45:38.207876+00:00
Cytek Biosciences, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | 5.08 | 723.8% | 47.4% | |||
| 30Δ | 5.44 | 685.9% | 44.0% | |||
| 35Δ | 5.80 | 647.9% | 40.6% | |||
| 40Δ | 6.16 | 610.0% | 37.1% | |||
| 45Δ | 6.52 | 572.1% | 33.7% | |||
| 50Δ | 6.89 | 534.2% | 30.3% | |||
| 55Δ | 7.25 | 496.2% | 26.8% | |||
| 60Δ | 8.99 | 756.7% | 89.8% | 7.61 | 458.3% | 23.4% |
| 65Δ | 6.92 | 667.2% | 55.5% | 7.97 | 420.4% | 20.0% |
| 70Δ | 5.77 | 616.8% | 38.4% | 8.33 | 382.5% | 16.5% |
| 75Δ | 8.69 | 344.5% | 13.1% | |||
| 80Δ | 9.05 | 306.6% | 9.7% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 5.08
- IV
- 723.8%
- B/E move
- 47.4%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 5.44
- IV
- 685.9%
- B/E move
- 44.0%
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 5.80
- IV
- 647.9%
- B/E move
- 40.6%
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.16
- IV
- 610.0%
- B/E move
- 37.1%
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.52
- IV
- 572.1%
- B/E move
- 33.7%
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.89
- IV
- 534.2%
- B/E move
- 30.3%
55Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 7.25
- IV
- 496.2%
- B/E move
- 26.8%
60Δ
- Pseudo strike
- 8.99
- IV
- 756.7%
- B/E move
- 89.8%
- Pseudo strike
- 7.61
- IV
- 458.3%
- B/E move
- 23.4%
65Δ
- Pseudo strike
- 6.92
- IV
- 667.2%
- B/E move
- 55.5%
- Pseudo strike
- 7.97
- IV
- 420.4%
- B/E move
- 20.0%
70Δ
- Pseudo strike
- 5.77
- IV
- 616.8%
- B/E move
- 38.4%
- Pseudo strike
- 8.33
- IV
- 382.5%
- B/E move
- 16.5%
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 8.69
- IV
- 344.5%
- B/E move
- 13.1%
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 9.05
- IV
- 306.6%
- B/E move
- 9.7%
Options history
No recorded observations
Medical Devices
CVRX
CVRx, Inc. develops implantable technology for the treatment of patients with high blood pressure / hypertension and heart failure.
More →DCTH
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company is…
More →DXCM
DexCom, Inc. is a company that develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with…
More →ELMD
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high-frequency chest wall oscillation (HFCWO) therapy in lung…
More →ENOV
Enovis Corporation is a global medical technology company. The company is headquartered in Wilmington, Delaware.
More →ESTA
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for cosmetic and reconstructive plastic surgery. The company is…
More →